D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.25 MYR -0.79% Market Closed
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Duopharma Biotech Bhd
Deferred Income Tax

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Duopharma Biotech Bhd
Deferred Income Tax Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Deferred Income Tax CAGR 3Y CAGR 5Y CAGR 10Y
D
Duopharma Biotech Bhd
KLSE:DPHARMA
Deferred Income Tax
myr17.7m
CAGR 3-Years
19%
CAGR 5-Years
10%
CAGR 10-Years
14%
P
PeterLabs Holdings Bhd
KLSE:PLABS
Deferred Income Tax
myr1m
CAGR 3-Years
9%
CAGR 5-Years
21%
CAGR 10-Years
N/A
A
Apex Healthcare Bhd
KLSE:AHEALTH
Deferred Income Tax
myr7.8m
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
3%
R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Deferred Income Tax
myr1.8m
CAGR 3-Years
65%
CAGR 5-Years
43%
CAGR 10-Years
N/A
Y
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
Deferred Income Tax
myr12.6m
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
5%
K
Kotra Industries Bhd
KLSE:KOTRA
Deferred Income Tax
myr2.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Duopharma Biotech Bhd
Glance View

Market Cap
1.2B MYR
Industry
Pharmaceuticals

Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.

DPHARMA Intrinsic Value
1.69 MYR
Undervaluation 26%
Intrinsic Value
Price
D

See Also

What is Duopharma Biotech Bhd's Deferred Income Tax?
Deferred Income Tax
17.7m MYR

Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Deferred Income Tax amounts to 17.7m MYR.

What is Duopharma Biotech Bhd's Deferred Income Tax growth rate?
Deferred Income Tax CAGR 10Y
14%

Over the last year, the Deferred Income Tax growth was 61%. The average annual Deferred Income Tax growth rates for Duopharma Biotech Bhd have been 19% over the past three years , 10% over the past five years , and 14% over the past ten years .

Back to Top